Book

Description

What if the key to stopping cancer lies in the smallest cells of your blood? In Platelet Receptors at the Crossroads of Hemostasis and Metastasis, I uncover a hidden truth: platelets are not just for clotting—they are used by tumors to fuel cancer growth, drive metastasis, and disarm the immune system. This book provides a comprehensive, step-by-step map of platelet receptor-mediated tumor progression—from primary tumor growth to distant metastasis. More importantly, it bridges hemostasis with oncology, critically examining emerging therapeutic strategies designed to disarm platelet-driven mechanisms. From αIIbβ3, GPVI, P-selectin, P2Y12, and PAR1 to tumor-specific receptors such as CLEC-2 and PD-L1, this volume explores how targeting platelet receptors can open new avenues for cancer therapy—with favorable bleeding risk profiles.